Stay updated on Cusatuzumab Combo for AML Clinical Trial
Sign up to get notified when there's something new on the Cusatuzumab Combo for AML Clinical Trial page.

Latest updates to the Cusatuzumab Combo for AML Clinical Trial page
- CheckyesterdayChange DetectedA new version entry (41) appears in the Record History with Study Status updates. The revision tag was updated to Revision: v3.5.4 on 2026-05-12, replacing the previous revision.SummaryDifference0.3%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page history now shows the latest revision as v3.5.3, replacing the previous v3.5.2. This reflects an update to the page's revision history rather than substantive changes to study details.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed from the history. These updates reflect internal version tracking rather than changes to study details.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3 in the release notes for the record history.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision notes updated: added entry for v3.4.3 and removed v3.4.2.SummaryDifference0.1%

- Check94 days agoChange DetectedA new revision label (v3.4.2) was added and older administrative notices (funding lapse notice and v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Cusatuzumab Combo for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cusatuzumab Combo for AML Clinical Trial page.